Core Viewpoint - Wei Dan International (02317) reported a revenue of $184 million for the six months ending June 30, 2025, representing a year-on-year decrease of 0.48% [1] - The profit attributable to shareholders was $7.598 million, down 8.8% year-on-year, with basic earnings per share at $0.005 [1] - The company proposed an interim dividend of $0.003 per share [1] Revenue Analysis - The decline in revenue is attributed to increasing competition in various markets, particularly affecting the sales prices and revenue of the company's main product, monosodium glutamate, due to a slowdown in consumer demand [1] - Despite a decrease in raw material and energy costs compared to last year, market competition has led to a decline in gross margin [1] Product Performance - Sales and revenue of modified starch decreased due to oversupply in Thailand, while the company's products maintained relatively high prices, resulting in reduced sales volume and revenue [1] - However, the decrease in raw material prices compared to the same period last year led to an increase in gross profit for modified starch [1] - Specialty products faced weak demand due to economic downturn and competition, prompting the company to lower prices to maintain sales, resulting in a slight revenue decrease compared to last year [1] Market Conditions - Hydrochloric acid revenue decreased due to weak market demand and continuous decline in average selling prices, despite slight reductions in raw material and energy costs [1] - The company is actively developing other product lines in the fertilizer and feed sector to address market competition and low demand [1] - Other products, such as coffee and bulk ingredients, saw revenue increases due to price hikes and sustained demand compared to last year [1]
味丹国际发布中期业绩，股东应占溢利759.8万美元，同比减少8.8%